Why do some women dismiss their breast cancer risk? new study investigates
NCT ID NCT06975085
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at why some women reject personalized breast cancer risk estimates. Researchers gave 781 Black or African American women aged 39-74 a personal risk score based on the Gail Model and asked if they agreed with it. The goal was to understand risk rejection and how it affects screening intentions, helping improve how risk information is shared.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Presentation of a personal breast cancer risk estimate
What this could lead to
If successful, this could help doctors better communicate breast cancer risk to women, leading to more informed screening choices.
What could go wrong
This is a completed behavioral study, not a treatment trial. It focuses on understanding reactions to risk information, not on changing health outcomes directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado
Aurora, Colorado, 80045, United States